Background {#Sec1}
==========

An extensive body of scientific evidence indicates that long-term exposure to ambient PM~2.5~ is associated with premature death, especially related to cardiovascular diseases \[[@CR1], [@CR2]\]. The biological mechanisms underlying this association are however incompletely understood. One important gap in our knowledge regarding these biological mechanisms is the lack of information about the time dependence of cardiovascular response to ambient PM~2.5~ exposure, in particular repeated or chronic exposure that is common in the real world.

Hypertension, also known as high blood pressure, is a major risk factor for cardiovascular morbidity and mortality \[[@CR3]\]. A recent meta-analysis has confirmed an association between exposure to ambient PM~2.5~ and increase in blood pressure (BP) \[[@CR4]\]. Notably, in contrast to the large number of controlled human exposure and toxicological studies showing the elevation of BP in response to short-term exposure to ambient PM~2.5~, there are few studies investigating the BP effect of chronic exposure to ambient PM~2.5~. Most recently, we showed that chronic exposure to concentrated ambient PM~2.5~ (CAP) significantly increased BP in C57Bl/6j mice \[[@CR5]\], likely through a central nervous system-dependent mechanism, supporting the hypothesis that the BP effect of chronic PM~2.5~ exposure may be associated with cardiovascular mortality. However, to verify the cause/effect relationship between them, a time dependency of BP response to chronic exposure to PM~2.5~ has yet to be determined.

Left ventricular hypertrophy (LVH), one of the most common complications of hypertension, has long been recognised as an important clinical prognostic entity and associated with increased cardiac morbidity and mortality \[[@CR6]\]. So far, one epidemiological study already showed that living in close proximity to major roadways is associated with higher left ventricular mass index \[[@CR7]\], suggesting that air pollution may also be associated with LVH in humans. We previously demonstrated that 12 weeks of exposure to CAP potentiated LVH of adult C57bl/6j mice in response to angiotensin II through RhoA/Rho kinase-dependent mechanisms \[[@CR8]\], and one year of exposure to CAP alone was even sufficient to induce LVH in C57Bl/6j mice \[[@CR9]\]. Consistent with this, Weldy et al. recently showed that exposure to diesel exhaust air pollution during *in utero* and early-life development in mice increases adult susceptibility to cardiac hypertrophy \[[@CR10]\]. However, the same group also demonstrated that up to 6 months of diesel exhaust exposure had no effect on cardiac hypertrophy and heart function induced by angiotensin II stimulation or pressure overload in adult C57BL/6j mice \[[@CR11]\], suggesting that further investigations on the association between ambient PM~2.5~ exposure and LVH are warranted.

In the present study, we exposed spontaneously hypertensive rats (SHR) to CAP, and investigated the time dependency of BP response to repeated exposure to CAP. To confirm the effect of CAP exposure on cardiac hypertrophy and test whether it is subsequent to hypertension, CAP exposure was withdrawn, and BP and cardiac function and hypertrophy were analysed at different time points.

Results {#Sec2}
=======

Exposure characterization {#Sec3}
-------------------------

The average ambient daily PM~2.5~ concentration during the exposure period was 10.9 ± 3.6 μg/m^3^. The in-chamber average concentration during CAP exposure was 128.3 ± 60.4 μg/m^3^ versus 2.2 ± 1.3 μg/m^3^ for FA exposure. Since the exposures were performed for 6 h/day, 5 days/week, the 24-h average CAP concentration was 31.8 μg/m^3^, which was significantly higher than the annual national ambient air quality standard of 12 μg/m^3^ set by the U.S. Environmental Protection Agency (U.S. EPA 2012). Black carbon in ambient PM~2.5~ and CAP during the exposure period was 492.5 ± 283.4 and 5,269.5 ± 2,616.2 ng/m^3^, respectively. Table [1](#Tab1){ref-type="table"} shows the elemental composition of the ambient PM~2.5~ and CAP during the exposure period. Notably, if expressed as percentage of total mass, the elemental composition of CAP is almost identical to that of ambient PM~2.5~, confirming that our versatile aerosol concentration enrichment system did not significantly alter the chemical composition of ambient PM~2.5~. Correlation analysis of mass and trace element concentrations from 25 5-day samples of ambient PM~2.5~ (a superset which includes the 15-week inhalation exposure period) showed that the two highest correlations with PM~2.5~ mass concentrations were for sulfur (*R*^*2*^ = 0.91) and selenium (*R*^*2*^ = 0.84). Although identifying PM~2.5~ emission sources is generally beyond the scope of this paper, the strong, simultaneous correlations of sulfur and selenium suggest that the study site was most strongly affected by secondary aerosols, which are likely to include emissions from coal-fired utility boilers located regionally \[[@CR12], [@CR13]\].Table 1Elemental data of ambient PM~2.5~ and CAPAmbient PM~2.5~CAPMean (ng/m^3^)SD%Mean (ng/m^3^)SD%Rb850.080.030.010.630.360.01Sr880.390.110.043.341.630.04Mo950.260.130.021.911.340.02Cd1110.270.210.032.272.180.03Sb1230.520.260.054.022.900.04Ba1372.631.320.2522.6016.190.25La1390.050.090.000.350.630.00Ce1400.040.010.000.320.170.00Pb2082.911.780.2720.6511.180.23Na23125.5253.8111.751081.31600.4612.08Mg2419.517.561.83185.13110.042.07Al2725.5611.222.39335.38442.813.75P317.634.320.71132.38158.121.48S32674.89223.3963.194760.373098.2753.16Ca4495.7335.938.961106.051092.7312.35Ti470.790.290.077.064.370.08V510.150.070.011.080.730.01Cr523.280.900.3141.3235.180.46Mn551.560.710.1513.638.210.15Fe5738.3013.773.59375.28224.374.19Co590.040.060.000.821.210.01Ni602.679.580.25256.581149.732.87Cu632.841.150.2739.1751.350.44Zn6612.015.691.12133.57125.251.49K3949.5316.764.64422.51219.534.72As750.360.170.032.922.400.03Se770.550.240.054.153.100.05Ambient PM~2.5~ and CAP were collected weekly, and their elemental composition was determined as previously described \[[@CR5]\]. The means and SDs of detectable elements and their percentages of ambient PM~2.5~ or CAP (%) are presented

Exposure to CAP induces reversible increase in BP {#Sec4}
-------------------------------------------------

Figure [1](#Fig1){ref-type="fig"} shows that 4 weeks of exposure to CAP was sufficient to significantly increased BP in SHR, and this significant difference in BP was observed throughout the remaining duration of exposure. To assess the time-dependency of this BP effects, after 15 weeks exposure, some rats were euthanized and the remaining were withdrawn from the exposure procedure. Figure [1](#Fig1){ref-type="fig"} shows that the significantly increased BP in CAP-exposed animals was maintained only in 2 weeks after withdrawal from exposure to CAP.Fig. 1Exposure to CAP induces reversible increase in blood pressure. **a**, Experimental design: SHR were exposed to CAP for 15 weeks. Blood pressure was measured weekly. Following echocardiography in week 20 and week 25, rats were euthanized for myography and tissue harvesting. **b**, the blood pressure response of SHR to repeated CAP exposure and subsequent withdrawal. \**p* \< 0.05 vs FA, two way ANOVA. *n* = 12 or 6/group

Exposure to CAP induces reversible vascular dysfunction {#Sec5}
-------------------------------------------------------

A number of studies have demonstrated a potent effect of CAP exposure on vascular function \[[@CR14]\], which may be implicated in the increased BP upon CAP exposure. Consistent with those studies, Fig. [2a--c](#Fig2){ref-type="fig"} show that exposure to CAP significantly increased the contractile responses of aortic rings to phenylephrine (a selective α1-adrenergic receptor agonist) and U-46619 (a stable synthetic analog of the endoperoxide prostaglandin PGH~2~), and significantly reduced the vasodilator action of acetylcholine. Furthermore, consistent with above results regarding BP, aortic contractile responses of SHR were almost completely restored after withdrawal from exposure to CAP for 5 weeks (Fig. [2d--f](#Fig2){ref-type="fig"}).Fig. 2Exposure to CAP induces reversible vascular dysfunction. SHR were euthanized shortly after 15 weeks of exposure to CAP (**a**--**c**, week 20) or 5 weeks of withdrawal from CAP exposure (**d**--**f**, week 25). Thoracic aorta were harvested and mounted to myography as described in Methods. The responses of isolated thoracic aorta to the indicated concentration of phenylephrine (PE, **a** and **d**), acetylcholine (Ach, **b** and **d**), and U-46619 (**c** and **f**) were analyzed, and results are presented as mean ± SEM. \**p* \< 0.05 vs FA, two way ANOVA. *n* = 6/group

Exposure to CAP induces reversible cardiac dysfunction and hypertrophy {#Sec6}
----------------------------------------------------------------------

Adverse echocardiographic effects of exposure to CAP have previously been demonstrated in mice \[[@CR9], [@CR10]\]. To assess the effects of exposure to CAP on cardiac function of SHR, echocardiography was performed before euthanization of rats. Figure [3a](#Fig3){ref-type="fig"} and [b](#Fig3){ref-type="fig"} show that 15 weeks of exposure to CAP significantly decreased stroke volume and cardiac output of SHR. No significant difference in other echocardiographic indexes was observed after 15 weeks of exposure to CAP (Week 20 in Table [2](#Tab2){ref-type="table"}). After withdrawal from exposure to CAP for 5 weeks, the decreased stroke volume and cardiac output was completely restored (Fig. [3c](#Fig3){ref-type="fig"} and [d](#Fig3){ref-type="fig"} and Table [2](#Tab2){ref-type="table"}).Fig. 3Exposure to CAP induces reversible cardiac dysfunction. SHR were subjected to echocardiography shortly after 15 weeks of exposure to CAP (**a** and **b**, week 20) or 5 weeks of withdrawal from CAP exposure (C and D, week 25). Stroke volume (**a** and **c**) and cardiac output (**b** and **d**) are presented. \**p* \< 0.05 vs FA, student's *t* test. *n* = 6/groupTable 2Echocardiographic dataWeek 20Week 25FACAPFACAPHR (BPM)355 ± 3.22320.2 ± 8.9367.4 ± 6.6348.2 ± 8.8Syst Diam (mm)3.9 ± 0.174.3 ± 0.34.1 ± 0.34.2 ± 0.21Dias Diam (mm)7.4 ± 0.16.5 ± 0.27.3 ± 0.236.9 ± 0.25Syst Vol (ul)70 ± 7.4598.5 ± 12.173.6 ± 14.1185.4 ± 9.7Dias Vol (ul)295.3 ± 8.5221.5 ± 1.35291.3 ± 10.4275.3 ± 11.2Ejec Frac (%)77.4 ± 1.6761.2 ± 3.974.4 ± 3.5169.4 ± 4.4LVAW;d (mm)2 ± 0.052 ± 0.072 ± 0.031.9 ± 0.07LVAW;s (mm)3.3 ± 0.072.7 ± 0.12.8 ± 0.093.1 ± 0.1LVID;d (mm)7.4 ± 0.16.9 ± 0.177.2 ± 0.096.9 ± 0.17LVID;s (mm)3.9 ± 0.134.2 ± 0.273.8 ± 0.24.2 ± 0.23LVPW;d (mm)2.5 ± 0.032.3 ± 0.12.3 ± 0.052.4 ± 0.09LVPW;s (mm)3.4 ± 0.022.9 ± 0.23.2 ± 0.13.1 ± 0.13SV~Dias-Syst~ (ul)226.4 ± 10.32123.6 ± 11.9^\*^217.4 ± 15.21190.2 ± 11.33Frac Short (%)48.4 ± 3.4836.2 ± 2.946.2 ± 1.8940.3 ± 2.47LV Mass (mg)1297 ± 246.81046 ± 229.41189 ± 219.71278 ± 347.7Echocardiography was performed before euthanization and results are presented as mean ± SEM*HR* heart rate, *Syst Diam* systolic diameter, *Dias Diam* diastolic diameter, *Syst Vol* systolic volume, *Dias Vol* diastolic volume, *Ejec Frac* ejection fraction, *LVAW;d* diastolic left ventricle anterior wall, *LVAW;s* systolic left ventricle anterior wall, *LVID;d* diastolic left ventricle internal dimension, *LVID;s* systolic left ventricle internal dimension, *LVPW;d* diastolic left ventricle posterior wall, *LVPW;s* systolic left ventricle posterior wall, *SV* ~*Dias-Syst*~ stroke volume calculated by the difference between Dias Vol and Syst Vol, *Frac Short* fractional shortening, *LV mass* left ventricle mass^\*^ *p* \< 0.05 versus FA, ANOVA

Cardiac hypertrophy is associated with BP and contributes to cardiac dysfunction and even mortality \[[@CR6]\]. We previously showed that chronic exposure to CAP induced cardiac hypertrophy in C57Bl/6j mice \[[@CR8]\]. To assess the effects of CAP exposure on cardiac mass of SHR, we weighed the body and organs of SHR. Figure [4a](#Fig4){ref-type="fig"} shows that 15 weeks of exposure to CAP significantly increased heart weight of SHR. In contrast, these CAP exposures did not significantly affect the weights of body and other organs (Table [3](#Tab3){ref-type="table"}). ACTA1, MYH7, and SERCA2 are well-known markers for cardiac hypertrophy. Consistent with organ weight data, Fig. [4b and c](#Fig4){ref-type="fig"} show that exposure to CAP significantly increased the protein levels of ACTA1 and MYH7, reinforcing that exposure to CAP induced cardiac hypertrophy in SHR. Cardiac hypertrophy subsequent to hypertension has been shown to regress after treatment of hypertension \[[@CR15]\]. Interestingly, Fig. [4e and f](#Fig4){ref-type="fig"} show that both heart weight and the expression of hypertrophic markers were restored after 5 weeks of withdrawal from exposure to CAP, supporting that exposure to CAP leads to cardiac hypertrophy probably through induction of hypertension.Fig. 4Exposure to CAP induces reversible cardiac dysfunction. **a**, the ratio of heart weight to body weight of SHR after 15 weeks of exposure to CAP (week 20). \**p* \< 0.05 vs FA, student's *t* test. *n* = 6/group. **b** and **c**, the cardiac protein levels of hypertrophic markers, ACTA1, MYH7, and SERCA2 after 15 weeks of exposure to CAP (week 20), as analysed by western blot. Representative images (**b**) and the summary (**c**) are presented. \**p* \< 0.05 vs FA, one way ANOVA. D, the ratio of heart weight to body weight of SHR 5 weeks of withdrawal from CAP exposure (week 25). \**p* \< 0.05 vs FA, student's *t* test. *n* = 6/group. **d** and **e**, the cardiac protein levels of hypertrophic markers, ACTA1, MYH7, and SERCA2 5 weeks of withdrawal from CAP exposure (week 25), as analysed by western blot. Representative images (**d**) and the summary (**e**) are presented. \**p* \< 0.05 vs FA, one way ANOVATable 3The weights of body and organsWeekBody weight (g)Liver weight (g)Spleen weight (g)Kidney weight (g)Epi-Fat weight (g)FACAPFACAPFACAPFACAPFACAP20322.1 ± 6.4311.9 ± 14.914.7 ± 1.113.5 ± 1.10.64 ± 0.020.63 ± 0.121.5 ± 0.21.4 ± 0.21.3 ± 0.21.3 ± 0.225348.4 ± 6.4339.1 ± 17.615.4 ± 1.214.8 ± 1.4NDNDNDND2 ± 0.32.2 ± 0.6The weights of body and the indicated tissues were measured during enthanization, and presented as mean ± SEM

Exposure to CAP induces reversible inflammation {#Sec7}
-----------------------------------------------

Systemic inflammatory response is believed to be subsequent to pulmonary inflammation and play a central role in the cardiovascular effects of chronic exposure to CAP \[[@CR16]\]. Consistent with this notion, Fig. [5a--c](#Fig5){ref-type="fig"} show that 15 weeks of exposure to CAP significantly increased the mRNA expression of TNFα, IL-6, and COX2 in lung, and TNFα in heart and hypothalamus. Notably, while 5 weeks of withdrawal from CAP exposure restored the mRNA expression of TNFα in heart and hypothalamus (Fig. [5e](#Fig5){ref-type="fig"} and [f](#Fig5){ref-type="fig"}), it did not restore the mRNA expression of TNFα and IL-6 in lung (Fig. [5d](#Fig5){ref-type="fig"}).Fig. 5Exposure to CAP induces reversible local and systemic inflammations. SHR were euthanized shortly after 15 weeks of exposure to CAP (**a**--**c**, week 20) or 5 weeks of withdrawal from CAP exposure (**d**--**f**, week 25). The mRNA expression levels of indicated pro-inflammatory cytokines in lung (**a** and **d**), hypothalamus (**b** and **e**), and heart (**c** and **f**) were assessed by real-time RT-PCR. \**p* \< 0.05 vs FA, one way ANOVA. *n* = 6/group

Discussion {#Sec8}
==========

In the present study, we investigated the time dependency of cardiovascular responses to chronic exposure to CAP and subsequent withdrawal. The main findings include: 1) that the time course of BP response to CAP exposure reinforces a cumulative mode of action of repeated exposure to ambient PM2.5 on BP; 2) that chronic exposure to CAP induced cardiac dysfunction and hypertrophy in SHR, and both were restored by withdrawal from exposure to CAP. Along with the time course of BP response, our present data support that the cardiac effects of CAP exposure may be secondary to its BP effect; 3) that in tune with BP response, extra-pulmonary inflammation were induced by chronic exposure to CAP and were restored by withdrawal from exposure, replicating the notion that the BP effect of chronic CAP exposure may be mediated by systemic inflammation; 4) that chronic exposure to CAP induced both pulmonary and extra-pulmonary inflammation, and withdrawal from exposure restored extra-pulmonary but not pulmonary inflammation, suggesting that pulmonary inflammation may be central in initiation but not maintenance of extra-pulmonary inflammation.

Hypertension is a well-known major risk for cardiovascular morbidity and mortality \[[@CR17]\]. A number of epidemiological and controlled exposure studies have indicated that exposure to ambient PM2.5 acutely increased BP in humans \[[@CR18]\], suggesting that the acute BP response to PM2.5 exposure may contribute to its associated morbidity and mortality. Toxicological studies also show that short-term exposure to CAP increase BP in several animal models including dogs \[[@CR19], [@CR20]\], SHR \[[@CR21]\], and WKY \[[@CR22]\]. In the present study, we however did not observe an acute increase in BP in response to CAP exposure. This may be due to the difference in timing of BP measurement. While BP was measured during or immediately following exposure to CAP in those previous toxicological studies, it was measured 16 h after the last exposure to CAP in the present study. Interestingly, if taken together, these studies indeed suggest that the elevated BP induced by short-term exposure to PM2.5 may last for only a short duration, necessitating more time course study in the future on acute BP response to PM2.5 exposure.

In the present study, our data reveal that chronic exposure to CAP significantly increased BP in SHR. This is consistent with our previous study showing that chronic exposure to CAP increased BP in C57Bl/6j mice \[[@CR5]\] and several epidemiological studies demonstrating associations between chronic exposure to PM2.5 and elevation in BP \[[@CR4]\]. There is evidence that the effects of chronic CAP exposure on allergic response, atherosclerosis, and lung development follow a cumulative mode of action \[[@CR23]\]. In contrast, the mode of action of chronic PM2.5 exposure on BP is not yet investigated. Interestingly, our data reveal a similar cumulative mode of action of chronic CAP exposure on BP, in particular in the term of the duration of elevation in BP: During the first 4 weeks of exposure, if there is any acute BP response, the duration of elevation in BP was less than 16 h; It was more than 16 h after 4 weeks of repeated exposure to CAP and was even up to 2 weeks after 15 weeks of exposure. To our knowledge, this is the first evidence that the BP effect of PM2.5 exposure may also follow a cumulative mode of action. Notably, the demonstration of this cumulative mode of action also somehow replicates that the aforementioned failure of identification of an acute BP response is indeed due to the timing of blood pressure measurement. Interestingly, consistent with several previous studies \[[@CR24], [@CR25]\], our data show that the BP effect of CAP exposure was paralleled by changes in vascular function (Fig. [2](#Fig2){ref-type="fig"}), suggesting that the CAP exposure-associated hypertension may be subsequent to vascular dysfunction.

LVH is a strong, independent predictor of cardiovascular events, including heart failure (HF) and all-cause mortality \[[@CR26]\]. Epidemiological study has already demonstrated an association between chronic exposure to PM2.5 and LVH \[[@CR7]\], and we previously showed that chronic exposure to CAP induced LVH in C57Bl/6j mice \[[@CR8]\]. In the present study, we replicated that chronic exposure to CAP increased heart weight in SHR, which was accompanied by cardiac dysfunction, reinforcing that it may be pathologically important. LVH has diverse causes, including both environmental and genetic factors, and hypertension is one of the most common causes for LVH \[[@CR26]\]. Since there is evidence that CAP exposure induces hypertension but absence of evidence that it changes other potential causes, it is likely that CAP exposure induces LVH through induction of hypertension. Hypertension-associated LVH has been shown to regress after success in control of BP \[[@CR27]\]. Interestingly, our present data show that 5 weeks of withdrawal from CAP exposure was sufficient to restore CAP exposure-induced cardiac dysfunction and hypertrophy, reinforcing the notion that CAP exposure-induced LVH is secondary to hypertension. However, the exact role of hypertension in CAP exposure-induced LVH has yet to be determined through manipulation of blood pressure.

Systemic inflammation is generally believed to be the major mediator of the cardiovascular effects of chronic exposure to ambient PM2.5 \[[@CR16]\]. Supporting this notion, our present data reveal that chronic exposure to CAP markedly increase pro-inflammatory cytokine expression in extra-pulmonary tissues including hypothalamus and heart, and the timing of increase in pro-inflammatory cytokine expression is in tune with those of hypertension and LVH: all were evident after 15 weeks of exposure to CAP, and were absent after 5 weeks of withdrawal from exposure. Notably, in spite of the importance of systemic inflammation in the toxicology of PM2.5 exposure, the mechanism whereby chronic exposure to CAP induces systemic inflammation remains unclear. In general, chronic PM2.5 exposure-induced extra-pulmonary inflammation is believed to be a spill-over of pulmonary inflammation, as previous time course studies demonstrated that pulmonary inflammation always precedes extra-pulmonary inflammation \[[@CR16]\]. Interestingly, our present data show that 5 weeks of withdrawal from exposure to CAP was sufficient to resolve inflammation in hypothalamus and heart but not lung, clearly demonstrating that increased expression of some pro-inflammatory cytokines in lung subsequent to CAP exposure is not sufficient to maintain extra-pulmonary inflammation.

Our study, although providing important new findings, has some limitations. These include the fact that due to the limited space of exposure chamber, no comparison between rats withdrawn from exposure and those maintained on exposure was performed, which is important to confirm the effects of withdrawal from exposure to CAP. For the same reason, the present study did not include normotensive animals. Given that our previous study demonstrated that exposure to CAP increases BP in normotensive animals such as C57Bl/6j mice \[[@CR5]\], it is warranted to determine if there is any difference between SHRs and their normotensive controls, WKYs, in the sensitivity to exposure to CAP. In addition, although together with previous demonstration of systemic inflammation-induced vascular dysfunction \[[@CR28], [@CR29]\], the restoring timings of PM2.5 exposure-induced systemic inflammation and vascular dysfunction in the present study support that PM2.5 exposure-induced vascular dysfunction results from systemic inflammation, the role of local vascular inflammation has yet to be determined.

Conclusion {#Sec9}
==========

Chronic exposure to CAP induces reversible cardiac dysfunction and hypertrophy, subsequent to the elevation in BP and induction of systemic inflammation. In addition, our data suggest that CAP exposure induces systemic inflammation probably through pulmonary inflammation-independent mechanism.

Methods {#Sec10}
=======

Whole-body ambient inhalational CAP exposures protocol {#Sec11}
------------------------------------------------------

The protocol of animal experiments was approved by the Ohio State University Institutional Animal Care and Use Committee, and all animals were treated humanely and with regard for alleviation of suffering. Animal exposure and the monitoring of exposure atmosphere and ambient aerosol were performed as previously described using a versatile aerosol concentration enrichment system that was modified for long-term exposures \[[@CR8]\]. Briefly, SHR (4-week-old males, n = 6/group, 24 in total) were bought from Charles River and were housed in standard cages in a mobile trailer with a 12-hr light/12-hr dark cycle, temperatures of 65--75 °F, and relative humidity of 40--60 %. After 1 week of acclimation, rats were exposed to CAP or filtered air (FA) in chambers of the Ohio Air Pollution Exposure System for the Interrogation of Systemic Effects at The Ohio State University. All rats, including both FA and CAP groups, were exposed at exactly the same time. FA-exposed rats received an identical protocol with the addition of a high-efficiency particulate air filter (Pall Life Sciences, East Hills, NY, USA) positioned in the inlet valve to remove CAP in the filtered air stream, as previously described \[[@CR8]\]. The exposure protocol comprised exposures for 6 h/day, 5 days/week (no exposure took place during weekends) for a total duration of 15 weeks.

Sampling and analyses of ambient PM~2.5~ and CAP in the exposure chamber {#Sec12}
------------------------------------------------------------------------

To calculate exposure mass concentrations of ambient PM~2.5~ and CAP in the exposure chambers, samples were collected weekly on Teflon filters \[Teflo, 37-mm, 2-μm pore (Pall Life Sciences, Ann Arbor, MI, USA)\] and weighed before and after sampling in a temperature- and humidity-controlled weighing room using a Mettler Toledo no. 11106057 microbalance (Mettler Toledo, Columbus, OH, USA). The filters were then wetted with ethanol and extracted in 1 % nitric acid solution. The extraction solution was sonicated for 48 h in an ultrasonic bath and then allowed to passively acid digest for a minimum of 2 weeks. We then analyzed sample extracts for a suite of trace elements using inductively coupled plasma-mass spectrometry (ICP-MS) (ELEMENT2; Thermo Finnigan, San Jose, CA, USA) \[[@CR30]\].

Blood pressure assessment {#Sec13}
-------------------------

The systolic blood pressure was obtained using a non-invasive tail-cuff monitor (MK2000; Muromachi Kikai, Tokyo, Japan). The measurement was performed weekly (Saturday morning). Before these analyses, all rats had been trained for 1 week. During assessment, the rats were placed into a holder which was pre-warmed and kept at 30 °C during the whole assessment and subjected to 20 measurements. The mean systolic blood pressure of these 20 measures for each animal were determined and presented.

Echocardiography {#Sec14}
----------------

Cardiac function was analysed by echocardiography (40 MHz transducer, Vevo 121 2100; Visualsonics, Toronto, Ontario), and the sonographer was blinded to the experimental groups during both data collection and analysis. Internal temperature was maintained at 37 °C as rats were continuously sedated with 1 % isoflurane (in 100 % O~2~) during assessment, which was about 1 h. Pre-warmed ultrasound gel (Aquasonic, Parker Labs, Fairfield, New Jersey) was used on the chest with a 15 MHz probe optimized for rats placed in the parasternal, short axis orientation. Data were averaged from at least three analyses per rat. LV dimensions (LVESd and LVEDd) and posterior wall thickness (PWTs and PWTd) were assessed, using the leading-edge technique according to the American Society for Echocardiography. Fractional shortening (FS) was calculated using the equation: % FS = \[(LVEDd-LVESd)/LVEDd\*100. Additional images were acquired to obtain aortic and pulmonary dimension, and pulse-wave Doppler imaging was used to obtain aortic and pulmonary velocities. Stroke volume (SV) was estimated utilizing the velocity time integral trace multiplied by the cross sectional area of the vessel, and this was used to calculate cardiac output (CO) as the product of SV and heart rate (HR). To determine the effects of withdrawal from CAP exposure on cardiac function, half rats were subjected to echocardiography shortly after CAP exposure, and the remaining were analysed after 5 weeks of withdrawal from CAP exposure.

Tissue preparation {#Sec15}
------------------

After anesthetized with pentobarbital sodium, rats were subjected to blood collection from hearts using a 22 g needle, and rapidly headed. Hypothalamus was isolated using incision sites as follows: rostral border of the optic chiasm, caudal border of the mamillary body, ventral border of the anterior commissure and lateral borders of the tuber cinereum and mamillary body complexes, and snap-frozen in liquid nitrogen. Thoracic aortas were proximally isolated and cut at the root. The whole heart was then isolated and placed on kimwipes to remove the remaining blood, and then snap-frozen in liquid nitrogen. All tissues were stored at −80 °C until processed.

Myography {#Sec16}
---------

Briefly, rats were anesthetized with pentobarbital sodium, and the thoracic aorta was quickly removed and cleaned in physiological salt solution (PSS) containing (mM): NaCl, 130; NaHCO~3~, 14.9; KCl, 4.7; KH~2~PO~4~, 1.18; MgSO~4~•7H~2~O 1.18; CaCl~2~•2H~2~O, 1.56, EDTA, 0.026, glucose 5.5. The aorta was cut into 2-mm rings, and were then mounted in a muscle bath containing PSS at 37 °C and bubbled with 95 % O~2~-5 % CO~2~. Isometric force generation was recorded with a Multi Myography System (Danish Myo Technology A/S, Aarhus N, Denmark). A resting tension of 30 mN was imposed on each ring, and the rings were allowed to equilibrate for 2 h. Arterial integrity was assessed first by stimulation of vessels with 80 mM KCl. Endothelium-integrity was assessed by measuring the dilatory response to ACh (10 μM) in PE-contracted vessels (1 μM). To examine the contractility of those aortic rings, phenylephrine (PE) or U-46619 was added in a cumulative manner. To test relaxation responses, aortic rings were pre-contracted by PE (0.3 μM) that induced approximately 60 % of maximal contraction, followed by addition of acetylcholine (ACh) in a cumulative manner.

Western blot analysis {#Sec17}
---------------------

About 1 g of left ventricle wall close to the apex of heart was cut on ice, and homogenized in M-PER Mammalian Protein Extraction Reagent (Pierce, Rockford, IL, USA). 40 μg/sample proteins were resolved with 10 % SDS-PAGE and transferred to membrane. Immuno-staining was performed by standard techniques with primary antibodies as follows: anti-GAPDH from Cell Signaling Technology (Boston, MA, USA); anti-ACTA1 from ABGENT (San Diego, CA, USA); anti-SERCA2 from Thermo Fisher Scientific (Rockford, IL, USA); and anti-MYH7 from GeneTex (Irvine, CA, USA). Signals were detected by supersignal™ chemiluminescence (Pierce, Rockford, IL, USA) and analysed by densitometry.

Quantitative real-time reverse transcription polymerase chain reaction (RT-PCR) {#Sec18}
-------------------------------------------------------------------------------

Total RNA was isolated from tissues with TRIzol reagent (Invitrogen, Carlsbad, CA, USA). 4 μg total RNA was reverse transcribed using random hexamers and the ThermoScript RT-PCR System (Invitrogen). Quantitative RT-PCR was performed with the Stratagene Mx3005 using SYBER Green PCR Master Mix (Applied Biosystems, Carlsbad, CA, USA). The sequences of primers were previously described \[[@CR31]\]: glyceraldehyde-3-phosphate dehydrogenase (GAPDH): sense, 5′-ATG ATT CTA CCC ACG GCA AG-3′, antisense, 5′-CTG GAA GAT GGT GAT GGG TT-3′; tumor necrosis factor-α (TNFα): sense, 5′-GAC CCT CAC ACT CA GAT CAT CTT CT-3′, antisense, 5′-TGC TAC GAC GTG GGC TAC G-3′; interleukin-6 (IL-6): sense, 5′-CGA GCC CAC CAG GAA CGA AAG TC-3′, antisense, 5′-CTG GCT GGA AGT CTC TTG CGG AG-3′); IL-1β: sense, 5′-CCC TGC AGC TGG AGA GTG TGG-3′, antisense, 5′-TGT GCT CTG CTT GAG AGG TGC T-3′; COX2: sense, 5′-GAT TGA CAG CCC ACC AAC TT-3′, antisense, 5′-CGG GAT GAA CTC TCT CCT CA-3′. The relative expression level was obtained as described previously with minor modification \[[@CR8]\]. Briefly, Ct values were acquainted through analysis with software provided by the manufacturer, and differences of Ct value between target gene and GAPDH (∆Ct) and then 2^∆Ct^ were calculated. Results were expressed as ratio to the average of FA group (fold).

Statistics {#Sec19}
----------

If not specified, data are expressed as mean ± SEM. Statistical comparisons of dose--response curves were performed with two-way repeated-measures analysis of variance (ANOVA) using GraphPad Prism version 4.0b (Graphpad Software Inc., La Jolla, CA, USA)\]. Otherwise, statistical comparisons were performed with one-way ANOVA or Student's *t*-test. p \< 0.05 was considered to be statistically significant.

PM~2.5~

:   Particulate matter with aerodynamic diameter less than 2.5 μm

FA

:   Filtered air

BP

:   Blood pressure

CAP

:   Concentrated ambient PM~2.5~

LVH

:   Left ventricular hypertrophy

SHR

:   Spontaneous hypertensive rat

ACTA1

:   Actin, alpha 1

MYH7

:   Myosin, heavy chain 7, cardiac muscle, beta

SERCA2

:   Sarco/endoplasmic reticulum Ca^2+^-ATPase 2
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